LionBio Therapeutics
United States
◆ About LionBio Therapeutics
Biotech startup developing nanoparticle-encapsulated nasal GLP-1 delivery technology, starting with intranasal semaglutide.
◆ Sectors
Biotech
◆ Funding rounds
◆ Explore the market
◆ FAQ
What does LionBio Therapeutics do?
Biotech startup developing nanoparticle-encapsulated nasal GLP-1 delivery technology, starting with intranasal semaglutide.
Where is LionBio Therapeutics based?
LionBio Therapeutics is based in United States.
How much has LionBio Therapeutics raised?
LionBio Therapeutics has raised $6M in tracked funding and is currently at the pre-seed stage.